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Human T-cell leukemia virus type 1 (HTLV-1) is a delta-type retrovirus that induces 
malignant and inflammatory diseases during its long persistence in vivo. HTLV-1 can 
infect various kinds of cells; however, HTLV-1 provirus is predominantly found in 
peripheral CD4 T cells in vivo. Here we find that TCF1 and LEF1, two Wnt 
transcription factors that are specifically expressed in T cells, inhibit viral replication 
through antagonizing Tax functions. TCF1 and LEF1 can each interact with Tax and 
inhibit Tax-dependent viral expression and activation of NF-κB and AP-1. As a result, 
HTLV-1 replication is suppressed in the presence of either TCF1 or LEF1. On the other 
hand, T-cell activation suppresses the expression of both TCF1 and LEF1, and this 
suppression enables Tax to function as an activator. We analyzed the thymus of a 
simian T-cell leukemia virus type 1 (STLV-1) infected Japanese macaque, and found a 
negative correlation between proviral load and TCF1/LEF1 expression in various T-cell 
subsets, supporting the idea that TCF1 and LEF1 negatively regulate HTLV-1 
replication and the proliferation of infected cells. Thus, this study identified TCF1 and 
LEF1 as Tax antagonistic factors in vivo, a fact which may critically influence the 
peripheral T-cell tropism of this virus.  
 
Significance Statement (120-word-maximum) 
HTLV-1 is a peripheral T-cell tropic virus and induces proliferation of CD4+ T cells, 
resulting in T-cell malignancy and inflammatory diseases. Recent studies demonstrated 
that several restriction factors inhibiting HIV are also inhibitory to HTLV-1. We 
identified two T-cell specific proteins, TCF1 and LEF1, as novel HTLV-1 restriction 
factors that determine the peripheral T-cell tropism of this virus by targeting Tax. They 
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are highly expressed in immature thymocytes and thereby become a natural intrinsic 
barrier for HTLV-1 replication in the thymus. However, their expression can be 
downregulated by Tax, as well as by activation and differentiation of T cells. These 
findings provide a mechanistic understanding of how HTLV-1 induces T-cell 





Human T-cell leukemia virus type 1 (HTLV-1) causes a malignancy named adult T-cell 
leukemia (ATL) and several inflammatory diseases including HTLV-associated 
myelopathy/tropical spastic paraparesis (HAM/TSP) (1, 2). HTLV-1 encodes a critical 
transactivator, Tax, that induces the activation and subsequent clonal expansion of 
infected T cells in vivo (2, 3). Tax is transcribed from the viral promoter 5’ long 
terminal repeat (LTR), where it further enhances HTLV-1 viral transcription by 
recruiting cellular CREB protein to Tax-responsive elements (TRE). However, Tax 
expression is frequently silenced in ATL cells due to genetic and epigenetic changes in 
the viral 5’ LTR and the tax gene (4-7), a possible consequence of host immune 
surveillance (8). On the other hand, the viral 3’ LTR remains intact and is responsible 
for consistent expression of the HTLV-1 bZIP factor (HBZ), a negative strand encoded 
accessory gene, in all ATL cells (9).  
   T-cell factor 1 (TCF1) and lymphoid-enhancer binding factor 1 (LEF1) are 
transcription factors of the Wnt pathway that bind to β-catenin to co-activate the 
downstream cascade (10, 11). They are predominantly expressed in T-lineage cells, 
with immature thymocytes having the highest expression (12). Thymocyte development 
was impaired in TCF1 knockout mice (13). Although LEF1 knockout didn't 
significantly affect T-cell development, deficiency in both TCF1 and LEF1 resulted in a 
complete block at the immature single positive stage, indicating a functional 
redundancy of TCF1/LEF1 and their indispensible role in driving T-cell development 
(14). In contrast, their functions in peripheral T-cells remain poorly characterized 
although a quite different role has been suggested due to their reduced expression upon 
T-cell receptor (TCR) engagement in CD8 T cells (15).  
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   HTLV-1 is peripheral mature T-cell tropic. However, the mechanism of this tropism 
remains to be elucidated. Here we find that TCF1 and LEF1 are novel T-cell intrinsic 
factors that suppress HTLV-1 replication via antagonizing Tax. They interact with Tax 
and suppress its transactivating abilities. As a result, viral transcription and replication 
are greatly suppressed by either TCF1 or LEF1, resulting in selective viral replication in 
TCF1/LEF1 low-expressing T cells. At the same time, Tax is able to downregulate 
TCF1/LEF1 by inducing STAT5a expression. We further demonstrate that thymocytes 
from a simian T-cell leukemia virus type 1 (STLV-1) infected Japanese macaque have 
low viral abundance and low 5’ LTR activity, negatively correlating with their high 





TCF1/LEF1 are expressed at low levels in HTLV-1 infected T cells. Previously we 
reported that HBZ impaired the DNA-binding ability of TCF1/LEF1 and thereby 
suppressed the canonical Wnt pathway, shaping an HTLV-1 favorable host environment 
(16). Interestingly, upon further study we found that TCF1 and LEF1 mRNA and 
protein levels were invariably low in HTLV-1 infected cell lines, in contrast to most 
HTLV-1 negative T-cell lines except Kit225 (Fig. 1A and B). Fresh ATL cells exhibited 
reduced expression of TCF1 and LEF1 compared with CD4 T cells from a healthy 
donor (Fig. 1C). Moreover, by analyzing microarray data of HTLV-1 infected 
individuals including asymptomatic carriers (AC), HAM/TSP and ATL patients 
(GSE19080 and GSE33615), we observed similar downregulation of TCF1 and LEF1 
(Fig. S1A and B).  
 
TCF1 and LEF1 interact with Tax and impair its transactivating ability. TCF 
family members have been recently reported to inhibit human immunodeficiency virus 
type 1 (HIV-1) basal transcription (17). Therefore, we analyzed effects of TCF1 and 
LEF1 on transcription from the HTLV-1 LTR. As observed in HIV-1, we found that 
Tax-mediated activation of WT-Luc, which contains five tandem repeats of the TRE 
from HTLV-1 5’ LTR, was inhibited by TCF1 or LEF1 (Fig. 2A). Moreover, activation 
of the NFκB and AP1 pathways by Tax was also suppressed by TCF1 or LEF1 (Fig. 2A). 
Neither the activator of the Wnt pathway β-catenin nor the inhibitor Axin2 had such 
effects (Fig. S2A), indicating that the effects of TCF1 and LEF1 were mediated in a 
Wnt-independent manner. Furthermore, neither TCF1 nor LEF1 could inhibit the 
activation of these reporters by other transcription factors (Fig. S2B), suggesting that 
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TCF1 and LEF1 specifically impair Tax function. We performed 
co-immunoprecipitation (co-IP) and found that TCF1 and LEF1 could each associate 
physically with Tax in vivo (Fig. 2B). Using a series of deletion mutants of Tax, we 
found that TCF1 and LEF1 predominantly bound to the C-terminal region of Tax (Fig. 
S2C). The PDZ-binding motif (PBM) is known to be localized in the C-terminal end of 
Tax (3). We found that removal of the PBM greatly impaired Tax binding to TCF1 or 
LEF1 (Fig. 2C), indicating that the PBM of Tax is critical for its binding with 
TCF1/LEF1. However, Tax bound to distinct regions of TCF1 and LEF1. The central 
regulation domain of TCF1 was indispensable for binding to Tax whereas all three 
domains were required for LEF1 to bind to Tax properly (Fig. S3A). Reporter assays 
with WT-Luc also functionally verified this result (Fig. S3B). 
   Nevertheless, due to their broad-spectrum antagonism of Tax, we suspected TCF1 
and LEF1 might competitively bind to Tax over other host factors that are hijacked by 
Tax for transactivation of the viral LTR. CREB is recruited by Tax for its activation of 
the HTLV-1 5’ LTR (3). We found that TCF1 or LEF1 dose-dependently displaced 
CREB from Tax (Fig. 2D), which suggests that TCF1 and LEF1 each hinder the 
interaction between Tax and CREB. Thus, these data demonstrate that TCF1 and LEF1 
are Tax antagonists that likely execute their inhibition via direct interaction with Tax.  
 
TCF1 and LEF1 inhibit HTLV-1 replication by antagonizing Tax. Next we 
examined the biological effects of this antagonism on Tax. HTLV-1 replication depends 
on Tax-driven transcription from the 5’ LTR. To address whether TCF1 and LEF1 are 
detrimental to HTLV-1 replication, we used an infectious clone of HTLV-1, pX1MT-M 
(18). HTLV-1 virus production measured by p19 ELISA was inhibited by TCF1 or 
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LEF1 in a dose-dependent manner (Fig. 3A). Furthermore, expression of viral proteins 
that rely on Tax, such as gp46, p19, p24 and even Tax itself, was suppressed by TCF1 
or LEF1 (Fig. 3A). We also found that endogenous TCF1 or LEF1 is also able to 
suppress HTLV-1 replication (Fig. S4).  
   On the other hand, HBZ transcription, which is initiated from viral 3’ LTR and 
slightly enhanced by Tax (19), was not suppressed but rather enhanced by TCF1 or 
LEF1 (Fig. 3B), in sharp contrast to Tax (Fig. 3B). To see whether this was associated 
with differential regulation of the HTLV-1 5’ and 3’ LTRs by TCF1/LEF1, we 
performed reporter assays with the complete 5’ and 3’ LTR sequences. Tax mildly 
activated the 3’ LTR, and this activation was enhanced by TCF1 or LEF1 (Fig. 3C). 
This explains why HBZ transcription increased in the presence of TCF1/LEF1 (Fig. 3B). 
Consistent with the WT-Luc result (Fig. 2A), TCF1 or LEF1 significantly suppressed 
Tax-induced 5’ LTR activation (Fig. 3C). To evaluate the effect of TCF1/LEF1 upon 
HTLV-1 de novo infection, we cocultivated Jurkat or normal CD4 T cells with lethally 
irradiated MT-2 cells. Tax expression was detected predominantly in the TCF1/LEF1 
low-expressing fraction (Fig. 3D), suggesting that TCF1/LEF1 restricts HTLV-1 de 
novo viral expression and its replication. 
 
Tax downregulates TCF1 and LEF1 via STAT5a. Antigen encounter or T-cell 
activation were reported to trigger TCF1/LEF1 downregulation (15). We confirmed that 
phorbol myristate acetate (PMA)/ionomycin (P/I) stimulation downregulate TCF1 and 
LEF1 in Jurkat and primary CD4 T cells (Fig. 4A and Fig. S5A). Therefore, we 
suspected that reduced expression of TCF1 and LEF1 in HTLV-1 infected cells is also 
caused by Tax, which is known to activate T cells (3). As expected, Tax induced the 
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expression of the same activation markers as P/I stimulation (Fig. S5B), and suppressed 
the expression of TCF1 and LEF1 in Jurkat cells (Fig. 4A). Furthermore, 
cadmium-induced Tax expression in JPX-9, a modified Jurkat line that expresses Tax 
under a metallothionein promoter (20), also downregulated TCF1 and LEF1 (Fig. 4B). 
However, Tax (Fig. S5C) did not inhibit transcription from the TCF1 and LEF1 
promoters. To see whether the NFκB, NFAT or AP1 pathways, the three major TCR 
downstream pathways, are involved in TCF1/LEF1 downregulation (21), we activated 
them by electroporation of the corresponding transcription factors into Jurkat (Fig. S5D). 
However, neither single nor combined activation of these pathways clearly suppressed 
TCF1 or LEF1 expression (Fig. S5E). JAK/STAT signaling, a major cytokine pathway 
of T cells that becomes active following T-cell activation (22), has been found to be 
constitutively active in HTLV-1 infected T cells (23). Since STAT proteins are 
transcription factors that activate this pathway (24), we examined the effect of STAT5a, 
which is reported to be a target of Tax (25). First, we confirmed that STAT5a 
expression was induced upon P/I stimulation and Tax expression (Fig. 4C). Then we 
overexpressed either the wild type or the constitutively active form of STAT5a in Jurkat 
cells, and found significantly decreased expression of TCF1 and LEF1 (Fig. 4D).  
 
Higher expression of TCF1 and LEF1 is associated with low STLV-1 proviral load 
in vivo. The above results suggest that Tax function and HTLV-1 replication are 
impaired in TCF1/LEF1 high expressing cells, most likely in thymocytes that express 
higher levels of TCF1/LEF1. To analyze the relationship between TCF1/LEF1 
expression and proviral load (PVL) in vivo, a model of HTLV-1 infection was required. 
We have reported that STLV-1 encoded Tax and STLV-1 bZIP factor (SBZ) possess 
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functions similar to those of HTLV-1 Tax and HBZ, and an STLV-1 infected Japanese 
macaque developed T-cell lymphoma (26), indicating that STLV-1 infected Japanese 
macaques can serve as a suitable model of HTLV-1 infection. STLV-1 Tax is highly 
homologous to HTLV-1 Tax (26). Similar to HTLV-1 Tax, it also has a typical 
PDZ-binding motif (ETDV) in its C-terminal end. We sorted various T-cell subsets 
from an STLV-1 infected Japanese macaque (Fig. S6) and found that CD4+CD8+ 
thymocytes (T-DP) showed the highest expression levels of TCF1 and LEF1 (Fig. 5A) 
whereas their PVL was the lowest (Fig. 5B). This is consistent with our hypothesis that 
TCF1 and LEF1 inhibit viral expansion through impairing both the function and 
expression of Tax (Fig. 2 and 3). CD4+ thymocytes (T-CD4) were about 2-fold higher 
in TCF1/LEF1 expression (Fig. 5A) than their counterparts in the periphery (P-CD4). 
However, the PVL of P-CD4 T cells was 10-fold higher than that of T-CD4 T cells (Fig. 
5B). Similar measurements were made in thymic (T-CD8) and peripheral CD8 T cells 
(P-CD8) (Fig. 5A and B). Interestingly, only a 1.3-fold increase of PVL in P-CD8 over 
T-CD8 was observed, in contrast to a 10-fold increase in P-CD4 over T-CD4 (Fig. 5B). 
Along with the fact that thymic CD8 and CD4 T cells had similar PVLs, this implies a 
much smaller expansion of infected CD8 T cells in the periphery than of CD4 T cells -- 
an observation in agreement with a previous report showing that HTLV-1’s in vivo 
tropism is a consequence of predominant expansion of peripheral CD4 over CD8 T cells 
(27).  
   Next we compared the levels of transcriptional activity from the 5’ and 3’ LTRs of 
the provirus in STLV-1 infected cells. We did this by normalizing either Tax or SBZ 
transcription to PVL. Recall that TCF1/LEF1 regulate transcription of these genes in 
opposing manners (Fig. 3B). The 5’ LTR was clearly more active in peripheral CD4 or 
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CD8 T cells than their thymic counterparts (Fig. 5C). In contrast, transcription from the 
3’ LTR was more active in thymocytes, although the differences were not so big as with 
the 5’LTR (Fig. 5D). Memory (CD45RA-) CD4 T cells from the spleen of the STLV-1 
infected Japanese macaque showed lower TCF1 and LEF1 expression but much higher 
PVL than naïve (CD45RA+) CD4 T cells (Fig. 5E and F), which is in agreement with 
the fact that HTLV-1 infected cells have mostly a memory phenotype (28). 
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Discussion 
During co-evolution between virus and the host, host cells acquire many restriction 
factors that suppress viral replication (29, 30). HTLV-1 is derived from STLV-1 in 
monkeys, just like HIV-1 is derived from SIV. Many restriction factors have been 
reported for HIV-1 (31). However, restriction factors for HTLV-1 have not been studied 
extensively. It has been reported that APOBEC3G suppresses replication of HTLV-1 
whereas Gag protein inhibits incorporation of APOBEC3G into the virion (32). 
Recently, SAMHD1 has been reported to suppress replication of HTLV-1 in monocytes 
(33). Tax is indispensable for HTLV-1 replication since expression of most viral genes, 
including all HTLV-1 structural genes, depends on transcription from the 5’ LTR that is 
activated by Tax. Moreover, Tax also plays a key role in dysregulating the cellular 
environment towards one which favors viral propagation, such by activation and 
transformation of an infected T cell (2). It is presumed that the T-cell tropism of 
HTLV-1 is more likely determined by postinfection events triggered by the virus since 
viral receptors are expressed in a wide variety of host cells (34). This study suggests 
that TCF1 and LEF1 are factors that restrict the tropism of this virus to peripheral T 
cells. In thymocytes expressing high levels of TCF1 and LEF1, these factors impair the 
functions of Tax, likely hindering not only viral replication but also the proliferation of 
the infected cells.  
   Restriction of tropism to peripheral T cells is likely a useful adaptation for HTLV-1. 
If HTLV-1 could replicate efficiently in the thymus, it might cause serious damage to 
the host immune system and thus the host. Furthermore, this virus is transmitted via 
breast-feeding or sexual transmission through infected T cells, so infected T cells must 
enter breast milk or semen. Most T cells in breast milk are peripheral T cells with an 
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effector/memory phenotype (35). Restriction by TCF1/LEF1 would explain viral 
tropism to peripheral T cells and facilitate transmission of the virus.  
   Neoplasm of immature T cells has not been reported in HTLV-1 infected 
individuals. However, transgenic expression of Tax in the thymus induced immature 
T-cell lymphomas (36). These findings suggest that overexpression of Tax is oncogenic 
even for thymocytes, but that Tax expression or functions are normally impaired in the 
thymus of infected individuals. This study presents a mechanism for how thymocytes 
are relatively resistant to HTLV-1 infection and leukemogenesis in vivo, by identifying 
TCF1 and LEF1 as antagonists for Tax. We discovered an unexpected Wnt-independent 
role of TCF1 and LEF1 as Tax antagonists and demonstrated that this antagonism 
renders thymocytes less permissive for HTLV-1 replication compared to peripheral T 
cells.  
   The roles of TCF1/LEF1 have been well established in the thymus; they are 
indispensable in driving T-cell development (37). Nevertheless, their functions in the 
periphery remain unknown. Recent studies showed that downregulation of TCF1/LEF1 
always occurs in activated or differentiated peripheral T cells (38).  HTLV-1 may 
exploit this downregulation to achieve its expansion, since downregulation of 
TCF1/LEF1 allows Tax to execute its functions. A previous report also indicated that 
pre-activated primary T cells are easier to transform by HTLV-1 (39). Downregulation 
of TCF1/LEF1 upon T-cell activation/differentiation would allow Tax expression and 
subsequent HTLV-1 expansion.  
   Downregulation of TCF1/LEF1 also occurs as T cells develop or differentiate, from 
DP to SP in the thymus (Fig. 5A), or from naïve to memory in the periphery (Fig. 5E). 
Therefore, our results also imply an interesting possibility that HTLV-1 might achieve 
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its expansion as infected T cells differentiate or even by driving differentiation of 
infected T cells to reduce TCF1/LEF1 expression. Indeed, a recent report using 
humanized mice showed altered T-cell development upon HTLV-1 infection in that the 
mature SP population, instead of immature DN or DP, becomes dominant in the thymus 
(40). This suggests that thymocytes are propelled to develop by HTLV-1 or the virus 
selectively expands in the more differentiated subsets. Similarly, in a previous study of 
peripheral T cells, we demonstrated that HTLV-1 infected T cells were mostly memory 
cells and the number of naïve cells was significantly decreased (28). Our current results 
also reveal the preferential infection of CD4 effector/memory T cells by STLV-1. 
However, in order to clarify the roles of T-cell development/differentiation in 
contributions of HTLV-1 expansion, further studies are needed.  
   STLV-1 infected Japanese macaque has been demonstrated to be a suitable model 
for HTLV-1 infection (26). It also served as an ideal model to analyze the impact of the 
antagonism of TCF1/LEF1 against Tax in vivo. However, due to the complexity of viral 
infections in vivo, other factors such as the susceptibility to viral infections, 
post-infection mitotic potential and cytotoxic T-cell killing efficiency might affect the 
consequence of an infection in a specific T-cell subset. Indeed, the tropism of the virus 
for peripheral CD4 T cells over peripheral CD8 T cells does not appear to be explained 
by TCF1/LEF1 levels. More detailed investigations in STLV-1 infected Japanese 
macaques are expected to clarify these points in the future. 
   TCF1/LEF1 regulate the HTLV-1 5’ and 3’ LTR activities in opposing manners via 
their interplay with Tax (Fig. 3C). This may result in distinct expression levels of Tax 
and HBZ in vivo in different T-cell subsets or during various stages of infection. 
Interestingly, valproate, a histone deacetylase inhibitor, was reported to induce Tax 
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expression while suppressing that of HBZ (41). These intriguing observations that the 
HTLV-1 5’ and 3’ LTR are regulated in opposite ways by multiple mechanisms -- in 
addition to frequently observed contradictory functions of Tax and HBZ -- may suggest 
a complex but fine-tuned viral pathogenesis. For instance, although activation of NF-κB 
pathway has been considered a critical function of Tax for cellular transformation (2, 3), 
the recent study have reported that hyper-activation of NF-κB pathway induces cellular 
senescence whereas HBZ suppresses this action of Tax, thereby enabling clonal 
expansion (42). This study shows that TCF1/LEF1 inhibit Tax medaited NF-κB 
activation by direct binding to Tax. Furthermore, TCF1/LEF1 inhibit various functions 
of Tax whereas HBZ selectively modulates signaling pathways (43, 44). Thus, Tax and 
HBZ collaboratively function for clonal expansion and viral replication while 
TCF1/LEF1 inhibit functions of Tax by direct interaction, which leads to suppression of 
viral replication and proliferation of infected cells.  
   In summary, we here identify TCF1 and LEF1 as novel Tax antagonists that likely 
restrict viral expansion in the thymus. The critical interplay of TCF1 and LEF1 with 
Tax during HTLV-1 infection may shed light on how HTLV-1 achieves its tropism and 
persistence in peripheral T cells in vivo. 
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Materials and methods 
Primary samples ethics statement 
The experiments using primary samples in this study were conducted according to the 
principles expressed in the Declaration of Helsinki. This study was approved by the 
Institutional Review Board of Kyoto University (approval numbers G310 and E2005). 
All ATL patients and healthy individuals provided written informed consent for the 
collection of samples and subsequent analysis. A Japanese macaque used in this study 
was 3 years old and naturally infected with STLV-1. The monkey was reared in the 
Primate Research Institute, Kyoto University. All animal studies were conducted in 
accordance with the protocols of experimental procedures approved by the Animal 
Welfare and Animal Care Committee of the Primate Research Institute (approval 
number 2011-095). 
Cell lines 
ATL-derived T-cell lines (HPB-ATL-2, HPB-ATL-T, ATL-43T-, ATL-43T+, 
ATL-55T+, ED, MT-1, and TL-Om1), HTLV-1-transformed T-cell lines (ATL-35T, 
Hut102, MT-2 and MT-4) were used in this study. Jurkat, CEM, Hut78, SupT1, Molt4 
and Kit225 are HTLV-1 negative T-cell lines. All T-cell lines were maintained in RPMI 
supplemented with 10% FBS, whereas Kit225, ATL-43T+ and ATL-55T+ were 
maintained in the media supplemented with 100 U/ml of recombinant IL-2. 293FT (Life 
technologies) is a subline of HEK293, which originated from a human embryonic 
kidney cell. 
Plasmids 
Expression vectors for TCF1, LEF1 and Tax were described previously (16, 45). 
Flag-CREB was made by subcloning the CREB coding sequence into pCAG-Flag. 
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WT-Luc and 5’ LTR-Luc were kind gifts from Dr. Fujisawa. pX1MT-M was a generous 
gift from Dr. Derse. NFκB-Luc and AP1-Luc were purchased from Stratagene. 3’ 
LTR-Luc was described previously (19). 
Antibodies 
Rabbit monoclonal antibodies for TCF1 (C63D9) and LEF1 (C12A5) were purchased 
from Cell Signaling Technology. HRP conjugated mouse anti-HA (12A5) antibody was 
purchased from Roche. Mouse monoclonal antibodies against HTLV-1 gp46, p24 and 
p19 were purchased from Zeptometrix. Mouse monoclonal antibodies for FLAG (M2), 
Myc (9E10), α-tubulin (DM1A) and Tax (MI73) were described previously (16). For 
flow cytometric analysis of cell surface markers, APC-Cy7 anti-CD3 (SP34-2), 
PerCP-Cy5.5 anti-CD4 (OKT4), V500 anti-CD8 (RPA-T8) and PE anti-CD45RA (5H9) 
were used. PerCP-Cy5.5 anti-CD4 (OKT4) was purchased from Biolegend while the 
others were from BD. 
Detection of Tax and TCF1/LEF1 by flow cytometry  
Intracellular staining for Tax and TCF1/LEF1 was performed using the kit from 
eBioscience. DyLight 649 conjugated donkey anti-rabbit IgG and FITC conjugated goat 
anti-mouse IgG were purchased from Biolegend. Normal mouse IgG was purchased 
from Santa Cruz and used for blocking nonspecific binding. 
ELISA 
Supernatants from cultured cells were centrifuged at 3000 rpm for 5 min to remove 
debris and then diluted and quantified for p19 by ELISA (Zeptometrix) according to 
manufacturer’s instructions.   
Sorting by FACS Aria II 
See supporting information for details (Fig. S6). 
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Electroporation, real-time PCR, knockdown, Western blot, co-immunoprecipitation and 
reporter assays were performed as previously described (16). 
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Fig. 1 TCF1 and LEF1 are expressed at low levels in HTLV-1-infected T-cells. (A) 
TCF1 and LEF1 mRNA expression is invariably low in HTLV-1 infected cell lines. 
Total RNA was extracted for each cell line and subjected to quantitative real-time PCR 
(qPCR) analysis. Results are shown as relative mRNA expression of TCF1 or LEF1 
normalized to that of 18S rRNA. (B) TCF1 and LEF1 protein expression of cell lines 
used in A. α-tubulin expression was used as a control. (C) TCF1 and LEF1 mRNA 
expression is lower in fresh ATL cases. Peripheral CD4 T cells from a healthy donor 
(HD) and four ATL patients were subjected to RNA extraction and following qPCR 
analysis. Results are shown as relative mRNA expression of TCF1 or LEF1 normalized 
to that of 18S rRNA. “Fold exp.” indicates fold expression of normalized mRNA level 
of TCF1 or LEF1. 
 
Fig. 2 TCF1 and LEF1 each interact with Tax and impair its transactivating ability. (A) 
TCF1 and LEF1 each repress Tax-mediated activation of WT-Luc (top), NFκB-Luc 
(middle) and AP1-Luc (bottom). Reporter assays were performed in Jurkat cells. (B) 
Physical interactions between TCF1 and Tax (top), and LEF1 and Tax (bottom). (C) A 
ΔPBM mutant of Tax has impaired binding to TCF1 (top) and LEF1 (bottom) compared 
to WT Tax. (D) Physical interactions between Tax and CREB are inhibited by TCF1 or 
LEF1 in a dose-dependent manner. Tax-specific bands are denoted *. All 




Fig. 3 TCF1 and LEF1 each inhibit HTLV-1 replication by antagonizing Tax. (A) TCF1 
and LEF1 each inhibits HTLV-1 production (top) and protein expression (bottom). 
pX1MT-M (0.5 µg) was transfected with or without TCF1 or LEF1 into 293FT cells. 48 
hours later, supernatants were collected for p19 ELISA and cells were lysed for western 
blot. (B) TCF1 and LEF1 each inhibit Tax transcription (bottom) but not HBZ 
transcription (top). pX1MT-M (0.5 µg) was transfected with or without TCF1 or LEF1 
into 293FT cells. 44 hours later, RNA was extracted for qPCR analysis. (C) TCF1 and 
LEF1 each slightly enhance Tax-mediated 3’ LTR-Luc (left) activation, whereas they 
significantly suppress 5’ LTR activation (right). Reporter assays were performed in 
Jurkat cells. (D) Jurkat or normal human CD4 T cells were either cultured alone (top) or 
cocultivated with lethally irradiated (150 Gy) MT-2 cells (bottom) at a 2:1 ratio. 48 
hours later (when MT-2 cells were all dead), cells were stained for intracellular Tax and 
TCF1 or LEF1. Numerals indicate percentages of gated populations. Fold exp. indicates 
fold expression. 
 
Fig. 4 Tax downregulates the expression of TCF1 and LEF1 via STAT5a  
(A) P/I stimulation (top) or Tax overexpression (bottom) inhibits TCF1/LEF1 
transcription in Jurkat. For P/I stimulation, cells were treated with 50 ng/ml of PMA and 
500 ng/ml of ionomycin (P/I) for 5 hours and then subjected to RNA extraction and 
qPCR analysis. Overexpression of Tax was achieved by electroporation and 24 hours 
later, RNA was extracted for qPCR. (B) Tax induction in JPX-9 downregulates the 
expression of TCF1 and LEF1. JPX-9 was cultured in RPMI supplemented with 20 µM 
of cadmium (Cd) to induce Tax expression. At indicated time points, cells were lysed 
for Western blot analysis. (C) P/I stimulation or Tax overexpression induces STAT5a 
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expression in Jurkat. P/I stimulation and Tax overexpression were performed as in A. (D) 
Overexpression of STAT5a downregulates TCF1 and LEF1. Jurkat was transfected with 
wild type (WT) or constitutively active (CA) STAT5a by electroporation. 24 hours later, 
RNA was extracted for qPCR. Fold exp. indicates fold expression. 
 
Fig. 5 TCF1 and LEF1 expression correlate negatively with STLV-1 proviral load in 
vivo 
(A) TCF1 (top) and LEF1 (bottom) transcription in sorted CD4/CD8 double positive 
(T-DP), CD4 single positive (SP) thymocytes (T-CD4), CD8 SP thymocytes (T-CD8) 
and peripheral CD4 (P-CD4) and CD8 (P-CD8) SP T-cells from an STLV-1 infected 
Japanese macaque, determined by qPCR. (B) Genomic DNAs of sorted T cells were 
analyzed for STLV-1 proviral load. Numerals indicate number of virus copies in 100 
cells. (C) Relative 5’ LTR activity of infected T cells. Tax mRNA expression was 
normalized to PVL of the same subset to represent relative transcription efficiency from 
5’ LTR. (D) Relative 3’ LTR activity of infected T cells determined by normalizing 
SBZ mRNA expression to PVL. (E) TCF1 (left) and LEF1 (right) mRNA expression in 
sorted CD3+CD4+CD45RA+ (naive) and CD45RA- (memory) T cells from the 
STLV-1 infected Japanese macaque, determined by qPCR. Fold exp. indicates fold 
expression. (F) Genomic DNAs of naïve and memory T cells were analyzed for 
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